Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 2019
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Background
Mechanisms underlying persistent cardiopulmonary symptoms after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (postacute sequelae of coronavirus disease 2019 [COVID-19; PASC] or “long COVID”) remain unclear. This study sought to elucidate mechanisms of cardiopulmonary symptoms and reduced exercise capacity.
Methods
We conducted cardiopulmonary exercise testing (CPET), cardiac magnetic resonance imaging (CMR) and ambulatory rhythm monitoring among adults >1 year after SARS-CoV-2 infection, compared those with and those without symptoms, and correlated findings with previously measured biomarkers.
Results
Sixty participants (median age, 53 years; 42% female; 87% nonhospitalized; median 17.6 months after infection) were studied. At CPET, 18/37 (49%) with symptoms had reduced exercise capacity (<85% predicted), compared with 3/19 (16%) without symptoms (P = .02). The adjusted peak oxygen consumption (VO2) was 5.2 mL/kg/min lower (95% confidence interval, 2.1–8.3; P = .001) or 16.9% lower percent predicted (4.3%-29.6%; P = .02) among those with symptoms. Chronotropic incompetence was common. Inflammatory markers and antibody levels early in PASC were negatively correlated with peak VO2. Late-gadolinium enhancement on CMR and arrhythmias were absent.
Conclusions
Cardiopulmonary symptoms >1 year after COVID-19 were associated with reduced exercise capacity, which was associated with earlier inflammatory markers. Chronotropic incompetence may explain exercise intolerance among some with “long COVID.”
Article activity feed
-
-
-
-
SciScore for 10.1101/2022.05.17.22275235: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The study was approved by the UCSF Committee on Human Research (IRB 20-33000) and all participants provided written informed consent.
Consent: The study was approved by the UCSF Committee on Human Research (IRB 20-33000) and all participants provided written informed consent.Sex as a biological variable Participants were excluded who were pregnant (to reduce confounding due to expected changes during pregnancy) or had significant cardiopulmonary disease including congenital heart disease, heart failure, myocardial infarction, or heart surgery. Randomization not detected. Blinding Samples were assayed blinded with respect to patient and clinical information, and assay performance was … SciScore for 10.1101/2022.05.17.22275235: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Ethics IRB: The study was approved by the UCSF Committee on Human Research (IRB 20-33000) and all participants provided written informed consent.
Consent: The study was approved by the UCSF Committee on Human Research (IRB 20-33000) and all participants provided written informed consent.Sex as a biological variable Participants were excluded who were pregnant (to reduce confounding due to expected changes during pregnancy) or had significant cardiopulmonary disease including congenital heart disease, heart failure, myocardial infarction, or heart surgery. Randomization not detected. Blinding Samples were assayed blinded with respect to patient and clinical information, and assay performance was consistent with the manufacturer’s specifications. Power Analysis not detected. Table 2: Resources
Software and Algorithms Sentences Resources Statistical Design: As we have previously reported, we defined a composite symptom variable for cardiopulmonary PASC including chest pain, dyspnea, or palpitations in the preceding 2 weeks prior to the study visit;7 all participants had new symptoms, were more than 3 months after SARS-CoV-2 infection, and did not have alternative cardiac disease to explain their symptoms, consistent with the WHO definition of PASC. PASCsuggested: (PASC , RRID:SCR_016642)REDCap was used for data entry. REDCapsuggested: (REDCap, RRID:SCR_003445)Statistical analyses were performed using STATA version 17.1 and additional visualization was done using R version 4.2.0 using the ggplot2 package. STATAsuggested: (Stata, RRID:SCR_012763)ggplot2suggested: (ggplot2, RRID:SCR_014601)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Others have attributed exercise limitations to ventilatory inefficiency from pulmonary vasculopathy,18 respiratory abnormalities,19 obesity and differences in cardiorespiratory fitness29 and deconditioning.20, 21 Impaired oxygen extraction at the peripheral level (assessed using invasive CPET) has also been suggested to explain reduced exercise capacity among those with PASC at 11 months after infection by Singh et al.31 However, they describe stopping CPETs once RER was greater than 1.10 or heart rate was >85% predicted, which is below maximal exercise for most individuals and does not allow evaluation of chronotropic incompetence. They hypothesize that autonomic regulation of microcirculatory function may be one mechanism by which SARS-CoV-2 may alter oxygen extraction during exercise.32 Others have hypothesized that IL-6 (which may be elevated in PASC)33 functions as a myokine that regulates energy allocation during exercise.34 We did not find differences in the VO2 work slope, a noninvasive correlate of peripheral oxygen extraction, but we did not measure peripheral oxygen extraction since we did not perform invasive CPET. Mancini et al and others have found that dysfunctional (rapid, erratic) breathing or exercise hyperventilation may contribute to symptoms of persistent dyspnea in PASC.35–37 In contrast, we did not observe dysfunctional breathing in any participant. Although not a universal finding, several other groups have also reported chronotropic incompetence in PA...
Results from TrialIdentifier: We found the following clinical trial numbers in your paper:
Identifier Status Title NCT04362150 Recruiting Long-term Impact of Infection With Novel Coronavirus (COVID-… Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
Results from scite Reference Check: We found no unreliable references.
-